Glucomancer – non-invasive continuous glucose monitor
- Peter van Berendonk
Diabetes mellitus is a metabolic disease affecting the creation or absorption of insulin in more than 400 million patients worldwide. Every six minutes someone dies due to medical complications directly caused by abnormally high or low blood glucose levels as a result of the disease. The single best method for mitigating this issue is treatment based on accurate and detailed data of a patient’s blood glucose levels.
In conjunction with Swinburne University and Dr Alicia Jenkins from the University of Sydney I have proposed a non-invasive glucose management solution in the form of the Glucomancer. Using the principles of bio-impedance spectroscopy, the Glucomancer sends a series of harmless radio waves that detect glucose in the interstitial fluid of they pass through. This provides diabetics with a quick, accurate and painless alternative to traditional blood tests or invasively implanted continuous monitoring devices.